Inluriyo
imlunestrant
Listed by Eli Lilly and Company
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Route
- Oral
- Class
- Estrogen Receptor Antagonist
What it contains
- Imlunestrant 200 mg/1
FDA record
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Estrogen Receptor Antagonist |
| Approval route | NDA — original brand approval |
| NDC code | 0002-1717 |
| FDA application | NDA218881 |
| RxNorm concept | 2725917 |
| Package sizes listed | 3 |
| Marketed since | September 2025 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.